Drug Type Small molecule drug |
Synonyms- |
Action partial agonists, antagonists |
Mechanism 5-HT2A receptor partial agonists(Serotonin 2a (5-HT2a) receptor partial agonists), 5-HT2B receptor antagonists(Serotonin 2b (5-HT2b) receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Preclinical | United States | 22 Apr 2025 | |
Neuropsychiatric syndrome | Preclinical | United States | 22 Apr 2025 |